Article

Eribulin represses effector T cell differentiation and enhances T cell-mediated anti-tumor activity to triple negative breast cancer cells through the facilitation of CD8+ T cell proliferation

2023-04-25

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose</bold> Chemotherapeutic agents exert immunomodulatory effects on triple-negative breast cancer (TNBC) cells and immune cells. Eribulin favorably affects the immunological status of patients with breast cancer. However, the effects of eribulin on the immune cells remain unexplored. The aim of this study was to investigate the effects of eribulin on immune cells.<bold>Method...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 82f114e4-2182-55bf-ad03-c25ce330fd9d
DOI: 10.21203/rs.3.rs-2844939/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Eribulin represses effector T cell differentiation and enhances T cell-mediated anti-tumor activity to triple negative breast cancer cells through the facilitation of CD8+ T cell proliferationDOI 10.21203/rs.3.rs-2844939/v1Read

Advances in immunotherapy for triple-negative breast cancerSemantic proximity Read

Estrogen deprivation triggers an immunosuppressive phenotype in breast cancer cellsSemantic proximity Read

A single-cell transcriptomic landscape of innate and adaptive intratumoral immunity in triple negative breast cancer during chemo- and immunotherapiesSemantic proximity Read

Hydroxypropyl-β-cyclodextrin inhibits the development of triple negative breast cancer by enhancing antitumor immunitySemantic proximity Read

Phenotypic shifts of tumor associated macrophages and STAT3 mediated suppression of myeloid derived suppressor cells drive sensitization of HER2 <sup>+</sup> tumor immunitySemantic proximity Read

Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells.Semantic proximity Read

Enhancing HLA-DR in Cytotoxic T Lymphocytes is crucial for the development of efficient adoptive T cell Therapies for Breast CancerSemantic proximity Read

p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancerSemantic proximity Read

CD40 agonism enhances immune checkpoint blockade and generates immunologic memory via CD4+ T cells in ERα+ mammary tumorsSemantic proximity Read

p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancerSemantic proximity Read

Antigen-Presenting B-Cell Signature Predicts Response and Survival in HER2-Positive Breast CancerSemantic proximity Read

ErbB/HER family in cancer immunology: therapeutic advances and mechanismsSemantic proximity Read